en

PRODUCT DETAIL

Rixathon 500 mg koncentrát na infúzny roztok

Code 4573C
MA number EU/1/17/1185/003
Product Form: con inf 1x50 ml/500 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XC Monoclonal antibodies
L01XC02 Rituximab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 15.06.2017
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 22.05.2023
eu-flag.png sk-flag.png